Clinical Analysis of Suction Drainage in Cementless Hip Replacement

April 1, 2020 updated by: Bartosz Paweł

Clinical Analysis of Suction Drainage in Cementless Hip Replacement - a Prospective Randomized Study

Randomized prospective study assessing suction drainage in total hip arthroplasty. Group without drainage, 50 hips, compared with group with suction drainage, 50 hips. Both groups will be asses clinically (ROM scale, VAS), laboratory and radiology (USG). In the actually literature there are no benefits using closed suction drainage after primary total hip arthroplasty.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age between 30-80
  • primary hip osteoarthritis

Exclusion Criteria:

  • secondary hip osteoarthritis
  • autoimmune disease
  • congenital or secondary coagulopathy
  • vein or artery thrombosis
  • renal or liver failure
  • cemented or hybrid alloplasty,
  • no consent from the patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: suction drainage
Patients will be dived with randomization in to two groups: with and without closed suction drainage after primary total hip arthroplasty
After primary total hip arthroplasty closed suction drainage will be used.
Active Comparator: no suction drainage
Patients will be dived with randomization in to two groups: with and without closed suction drainage after primary total hip arthroplasty
After primary total hip arthroplasty closed suction drainage won't be used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip hematoma size in USG
Time Frame: 3 days after surgery
Size in millimeters fluid collection in supine position above femoral neck.
3 days after surgery
Hemoglobin levels
Time Frame: 3 days after surgery
Hb levels after surgery, difference between two groups
3 days after surgery
C-reactive protein levels
Time Frame: 3 days after surgery
C-reactive protein levels after surgery, difference between two groups
3 days after surgery
Visual Analog Scale punctation
Time Frame: 3 day after surgery
Pain level after surgery in Visual Analog Scale scale 0-10 pts. where 0-no pain, 10-most painful.
3 day after surgery
Hip range of movement
Time Frame: 3 days after surgery
Differences between hip ROM after surgery
3 days after surgery
Wound exudation
Time Frame: 3 days after surgery
Assessing wound dehiscence after surgery, 1-exudation appear, 0-dry dressing
3 days after surgery
Soft tissue hematoma
Time Frame: 3 days after surgery
USG hematoma appearance in soft tissue around the hip
3 days after surgery
Intraoperative bleeding
Time Frame: 1 day
All amount of blood loss intraoperative with hidden bleeding, with use of Gross formula.
1 day
Blood transfusion
Time Frame: 14 days after surgery
Need of blood transfusion after operation
14 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infection
Time Frame: 30 days after surgery
Superficial or deep infection after surgery
30 days after surgery
Deep vein thrombosis
Time Frame: 30 days after surgery
Occurrence lower limb thrombosis after surgery
30 days after surgery
Readmission
Time Frame: 30 days after surgery
Need to readmission after surgery
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Pawel Bartosz, Prof. A. Gruca Teaching Hospital in Otwock

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

January 1, 2020

Study Completion (Actual)

February 1, 2020

Study Registration Dates

First Submitted

March 30, 2020

First Submitted That Met QC Criteria

April 1, 2020

First Posted (Actual)

April 3, 2020

Study Record Updates

Last Update Posted (Actual)

April 3, 2020

Last Update Submitted That Met QC Criteria

April 1, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1/032016

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthropathy of Hip

Clinical Trials on suction drainage

3
Subscribe